IL-1 and TNF-α but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR

Acta Oto-Laryngologica

Volumn 116, Issue 1, 1996, Pages 132-136

  Knerer, Birgit ^a   Hulla, Wolfgang ^a   Martinek, Helga ^a   Formanek, Michael ^a   Temmel, Andreas ^a   Kornfehl, Johannes ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokine expression; Head and neck cancer; RT PCR

Indexed keywords

CYTOKININ; INTERLEUKIN 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

EID: 0029671194     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489609137726     Document Type: Article

References (25)

1. Klein G, Boon T. Tumor immunology: present perspectives. Curr Opin Immunol 1993; 5: 687-92.
2. Swain SL. Lymphokines and the immune response: the central role of interleukin-2. Curr Opin Immunol 1991; 3: 304-10.
3. Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2 activated natural killer cells. J Immunol 1992; 149: 340-9.
4. Lotze MT. T-cell growth factors and the treatment of patients with cancer. Clin Immunol Immunopathol 1992; 62: S47-54.
5. Rosenberg SA, Lotze MT, Yang GC, et al. Experience with the use of high-dose interleukin 2 in the treatment of 652 cancer patients. Ann Surg 1989; 210: 475-85.
6. Rivoltini L, Gambacorti-Passerini C, Massimo S-S, et al. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors. Cancer Res 1990; 50: 5551-7.
7. Whiteside TL, Letessier E, Hirabayashi H, et al. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res 1993; 53: 5654-62.
8. Wong FS, Hibberd ML, Wen L, Millward BA, Demaine AG. The human T cell receptor repertoire of normal peripheral blood lymphocytes before and after mitogen stimulation. Clin Exp Immunol 1993; 92: 361-6.
9. Kornfehl J, Neuchrist C, Grasl MC, Ehrenberger K, Kraft D, Scheiner O. The expression and cellular distribution of adhesion molecules CD2/LFA-3 and ICAM-1/LFA-1 on mononuclear cells in squamous cell carcinoma of the head and neck. Eur Arch Otolaryngol 1993; 250: 1168-72.
10. Neuchrist C, Grasl MC, Scheiner O, Ehrenberger K, Lassman H, Kraft D. Phenotype of mononuclear phagocytes infiltrating squamous cell carcinomas of the head and neck. Br J Cancer 1991; 62: 7448-53.
11. Sacchi M, Klapan I, Johnson J, Whiteside TL. Antiproliferative effects of cytokines on squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 321-6.
12. Yasumura S, Hirabayashi H, Schwartz DR, et al. Human cytotoxic T-cell lines with restricted specificity for SCCHN. Cancer Res 1993; 53: 1461-8.
13. Cortesina G, Sacchi M, Galeazzi E, Johnson JT, Whiteside TL. Interleukin 2 receptors on squamous cell carcinomas of the head and neck. Acta Otolaryngol (Stockh) 1992; 112: 370-5.
14. Weidmann E, Sacchi M, Plaisance S, et al. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res 1992; 52: 5963-70.
15. Gallo O, Pinto S, Boccuzzi S, et al. Monocyte tumor necrosis factor production in head and neck squamous cell carcinoma. Laryngoscope 1992; 102: 447-50.
16. Parks R, Yan SD, Huang C-C. Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma. Laryngoscope 1994; 104: 860-4.
17. Pisa P, Halapi E, Pisa EK, et al. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. PNAS 1992; 89: 7708-12.
18. Kazuki T, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143-8.
19. UICC 1987. TNM classification of malignant tumors. 4th ed. Berlin, Heidelberg, New York: Springer Verlag, 1987.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A laboratory manual. Cold Spring Harbor: Laboratory Press, 1989.
21. Van Kerckhove C, Russell GJ, Deusch K, et al. Oligoclonality of human intestinal intraepithelial T cells. J Exp Med 1992; 175: 57-63.
22. Hatakeyama M, Taniguchi T. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors 1; New York: Springer 1990: 523.
23. Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol 1992; 10: 411-52.
24. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-20.
25. Klein E, Mantovani A. Action of natural killer cells and macrophages in cancer. Curr Opin Immunol 1993; 5: 714-8.